The feasibility of existing JADAS10 cut-off values in clinical practice: a study of data from The Finnish Rheumatology Quality Register
Abstract Background The ten-joint juvenile arthritis disease activity score (JADAS10) is designed to measure the level of disease activity in non-systemic juvenile idiopathic arthritis by providing a single numeric score. The clinical JADAS10 (cJADAS10) is a modification of the JADAS10 that excludes...
Saved in:
Main Authors: | M. Backström (Author), H. Salo (Author), J. Kärki (Author), K. Aalto (Author), K. Rebane (Author), T. Levälampi (Author), M-M. Grönlund (Author), L. Kröger (Author), H. Pohjankoski (Author), M. Hietanen (Author), K. Korkatti (Author), L. Kuusalo (Author), V. Rantalaiho (Author), J. Huhtakangas (Author), H. Relas (Author), T. Pääkkö (Author), E. Löyttyniemi (Author), T. Sokka-Isler (Author), P. Vähäsalo (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2023-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Etanercept for patients with juvenile idiopathic arthritis: drug levels and influence of concomitant methotrexate: observational study
by: Tiina Levälampi, et al.
Published: (2023) -
Pain-coping scale for children and their parents: a cross-sectional study in children with musculoskeletal pain
by: Maria Backström, et al.
Published: (2023) -
Juvenile Arthritis Disease Activity Score (JADAS) based on CRP; validity and predictive ability in a Nordic population-based setting
by: Fasth A, et al.
Published: (2011) -
Economic evaluation of infliximab, synthetic triple therapy and methotrexate in the treatment of newly diagnosed juvenile idiopathic arthritis
by: Maarit Tarkiainen, et al.
Published: (2022) -
Efficacy and safety of anti-TNF agents in patients with enthesitis related arthritis
by: Tynjälä P, et al.
Published: (2008)